Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 535.2K | 336.1K | 343.7K | 298.3K |
Selling general and admin | 1.8M | 733.7K | 970.4K | 839.8K |
Other operating expenses | — | — | — | — |
Operating income | -2.3M | -1.1M | -1.3M | -1.1M |
Non operating interest income | ||||
Income | 20.5K | 20.0K | 22.8K | 35.0K |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -2.3M | -1.0M | -1.3M | -1.1M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -2.3M | -1.0M | -1.3M | -1.1M |
Basic EPS | -2.1 | -1.3 | -1.8 | -1.5 |
Diluted EPS | -2.1 | -1.3 | -1.8 | -1.5 |
Basic average shares | 1.1M | 916.0K | 770.3K | 770.3K |
Diluted average shares | 1.1M | 916.0K | 770.3K | 770.3K |
EBITDA | -2.3M | -1.1M | -1.3M | -1.1M |
Net income from continuing op. | -2.3M | -1.0M | -1.3M | -1.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |